Fortress Biotech

Board room C-suite meeting contract
Pharma

Fortress sells FDA voucher for $205M after Zycubo approval

The trend of rising FDA voucher prices is continuing as 2026 plays out, with another transaction now valued at $200 million or more.
Eric Sagonowsky Feb 23, 2026 10:15am
red light green light

Sentynl, Cyprium score FDA nod for 1st med for Menkes disease

Jan 13, 2026 10:45am
end of the road road block shut down closed blocked
Favicon Fierce Biotech

FDA snubs Fortress' Zydus-partnered Menkes disease candidate

Oct 1, 2025 12:00pm
A close-up view of a jigsaw puzzle with a missing piece
Favicon Fierce Biotech

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am